Advanced image guidance more precisely targets sarcomas, reduces long-term side effects
the ONA take:
Image-guided radiotherapy can effectively treat soft tissue sarcomas in the extremities, significantly reducing long-term side effects without effecting survival rates, according to RTOG 0630, a multi-year, multi-institution phase 2 clinical trial conducted by the Radiation Therapy Oncology Group (RTOG), now conducting research as NRG Oncology.
For this study, more than 100 patients with extremity-based soft tissue sarcomas (STS) received pretreatment radiation therapy that used advanced imaging technology to target a substantially smaller area than typically targeted in treating this type of cancer.
A series of daily presurgery images of the tumor were digitally integrated with previous scans to plan a custom-tailored radiation dose that minimized exposure to adjacent healthy tissue.
Assessments 2 years later showed that long-term side effects were 10.5%. Results from a previous study in which patients received radiation to a larger area showed long-term side effects of 37%.
“Although radiation oncology is a technologically intense discipline, wisdom in using these technologies is essential for optimal outcomes,” commented the lead author of the paper.
Image-guided radiotherapy can effectively treat soft tissue sarcomas in the extremities.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|